Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV biperiden crossover challenge study in healthy elderly subjects
NL-OMON51272Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of biperiden (3 arms), sponsored by Centre for Human Drug Research. Primary endpoints: CNS pharmacodynamic profile of IV biperiden, Saccadic eye movements and 15 more. Started Feb 2022; status: active, not recruiting.
02
Drugs
biperiden
Beyond the preview
Go deeper on NL-OMON51272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51272.